XPS is a fully integrated EVLP system containing all necessary components to facilitate ex-vivo lung perfusion using STEEN Solution. Smart sequencing and continuous data recording guides the perfusionist through the EVLP protocol. Data is continuously recorded, to be evaluated for safety and control.

The XVIVO Perfusion System (XPSTM) is intended for flushing and temporary continuous normothermic machine perfusion of isolated lungs, during which time the function of the lungs can be assessed for transplantation (for all other countries).

The XVIVO Perfusion System (XPSTM) with STEEN SolutionTM Perfusate is indicated for the flushing and temporary continuous normothermic machine perfusion of initially unacceptable excised donor...

Normothermic ex vivo lung perfusion (EVLP), assessment of poorly functioning donor lungs with unknown questionable function permits a more rational utilization of potentially acceptable organs which are currently often discarded despite the relatively reversible nature of their imperfections.

Normothermic Ex Vivo Lung Perfusion (EVLP) is a method used to assess donated lungs ahead of transplantation. It entails connecting the lungs to a machine and perfusing them with STEEN Solution upon arrival at the transplant clinic. The lungs are warmed to body temperature with a pump, providing circulation and a ventilator simulating breathing.

THE SCANDINAVIAN EVLP METHOD The XVIVO LSTM enables evaluation of marginal donor lungs according to a complete and standardized method. STEEN SolutionTM HCT of 10-15% Perfusion flow: 100% cardiac output

2019年3月1日 · Ex vivo lung perfusion (EVLP) is a significant advancement in donor lung preservation. It addresses two key issues in lung transplantation: donor availability and donor quality.

In the last decade, ex vivo lung perfusion (EVLP) has expanded the donor pool by allowing prolonged evaluation of marginal donor lungs and allowing reparative therapies for lungs, which are otherwise considered not transplantable.

(EVLP) using the XVIVO Perfusion SystemTM (XPSTM) with STEE of Grade 3 primary graft dysfunction (PGD) at 72 hours post‐transplant. Secondary endpoints include PGD score at 24 and 48 hours, ICU...

Ex vivo lung perfusion implies perfusion and ventilation of a donor lung outside of the human body. The 2 most clinically relevant and commercially available devices currently in clinical trials are XVIVO Perfusion System (XPS Perfusion, Goteborg, Sweden) and Organ Care System (Transmedics, Andover, MA).